{"id":826446,"date":"2025-03-17T13:33:14","date_gmt":"2025-03-17T17:33:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/"},"modified":"2025-03-17T13:33:14","modified_gmt":"2025-03-17T17:33:14","slug":"maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/","title":{"rendered":"Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action Lawsuit"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">March 17, 2025<\/span><\/span> \/PRNewswire\/ &#8212; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4384486-1&amp;h=137722675&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Fmaravai-lifesciences-holdings-inc-nasdaqmrvi%2F&amp;a=Wolf+Haldenstein+Adler+Freeman+%26+Herz+LLP\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/a> announces the filing of a securities class action lawsuit against Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). This lawsuit, filed on behalf of those who purchased Maravai securities between <span class=\"xn-chron\">August 7, 2024<\/span>, and <span class=\"xn-chron\">February 24, 2025<\/span>, <span>alleges<\/span> that the company made materially misleading statements and failed to disclose crucial information to investors.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2642979\/Wolf_Haldenstein_Adler_Freeman_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2642979\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\" title=\"(PRNewsfoto\/Wolf Haldenstein Adler Freeman )\" alt=\"(PRNewsfoto\/Wolf Haldenstein Adler Freeman )\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>The complaint <span>alleges<\/span> several key issues. Specifically, it claims Maravai lacked sufficient internal controls over financial reporting concerning revenue recognition, leading to inaccurate revenue reporting for fiscal year 2024. Furthermore, the lawsuit <span>alleges<\/span> that the company&#8217;s goodwill was overstated. These <span>alleged<\/span> inaccuracies, the complaint contends, resulted in materially misleading statements about Maravai&#8217;s business, operations, and future prospects.<\/p>\n<p>If you suffered financial losses during the class period and believe your investment was impacted by these <span>alleged<\/span> misrepresentations, act now. The deadline to request appointment as lead plaintiff is <span class=\"xn-chron\">May 5, 2025<\/span>. Contact <b><a href=\"mailto:classmember@whafh.com\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Wolf Haldenstein<\/span><\/a><\/b> to learn more about your legal rights and options.<\/p>\n<p>The lawsuit centers on the claim that Maravai&#8217;s public statements were deceptive due to undisclosed internal control weaknesses and inaccurate financial reporting. This <span>alleged<\/span> lack of transparency potentially harmed investors who relied on the company&#8217;s representations when making investment decisions. The <span>alleged<\/span> misstatements and omissions are detailed in the filed complaint.<\/p>\n<p>The potential impact of this lawsuit could be significant for Maravai and its investors. A successful outcome could result in financial compensation for those who purchased the company&#8217;s securities during the specified period. The case highlights the importance of accurate and transparent financial reporting for publicly traded companies.<\/p>\n<p>The specifics of the <span>alleged<\/span> misrepresentations and the potential remedies available to affected investors are detailed in the legal complaint. For further details, including information on how to participate in the class action, please contact <span class=\"xn-person\">Wolf Haldenstein<\/span> at <b><a href=\"mailto:classmember@whafh.com\" target=\"_blank\" rel=\"nofollow\">classmember@whafh.com<\/a><\/b> . Don&#8217;t delay; contact us before the <span class=\"xn-chron\">May 5, 2025<\/span> deadline.<\/p>\n<p>Media Contact: Contact:\u00a0Wolf Haldenstein Adler Freeman &amp; Herz LLPGregory Stone, Director of Case and Financial AnalysisEmail: <a href=\"mailto:gstone@whafh.com\" rel=\"nofollow\">gstone@whafh.com<\/a> or <a href=\"mailto:classmember@whafh.com\" target=\"_blank\" rel=\"nofollow\">classmember@whafh.com<\/a>Tel: (800) 575-0735 or (212) 545-4774\u00a0This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p>\n<p>\n        <span class=\"xn-person\">Wolf Haldenstein<\/span> has experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas, and offices in <span class=\"xn-location\">New York<\/span>, <span class=\"xn-location\">Chicago<\/span>, <span class=\"xn-location\">Nashville<\/span> and <span class=\"xn-location\">San Diego<\/span>. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact <span class=\"xn-person\">Wolf Haldenstein<\/span> by telephone at (800) 575-0735 or via e-mail at <a href=\"mailto:classmember@whafh.com\" target=\"_blank\" rel=\"nofollow\">classmember@whafh.com<\/a>.<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY42525&amp;sd=2025-03-17\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit-302403312.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit-302403312.html<\/a><\/p>\n<p>SOURCE  <span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY42525&amp;Transmission_Id=202503171330PR_NEWS_USPR_____NY42525&amp;DateId=20250317\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK , March 17, 2025 \/PRNewswire\/ &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP announces the filing of a securities class action lawsuit against Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). This lawsuit, filed on behalf of those who purchased Maravai securities between August 7, 2024, and February 24, 2025, alleges that the company made materially misleading statements and failed to disclose crucial information to investors. The complaint alleges several key issues. Specifically, it claims Maravai lacked sufficient internal controls over financial reporting concerning revenue recognition, leading to inaccurate revenue reporting for fiscal year 2024. Furthermore, the lawsuit alleges that the company&#8217;s goodwill was overstated. These alleged inaccuracies, the complaint contends, resulted in materially misleading statements about Maravai&#8217;s &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action Lawsuit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-826446","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action Lawsuit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action Lawsuit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , March 17, 2025 \/PRNewswire\/ &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP announces the filing of a securities class action lawsuit against Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). This lawsuit, filed on behalf of those who purchased Maravai securities between August 7, 2024, and February 24, 2025, alleges that the company made materially misleading statements and failed to disclose crucial information to investors. The complaint alleges several key issues. Specifically, it claims Maravai lacked sufficient internal controls over financial reporting concerning revenue recognition, leading to inaccurate revenue reporting for fiscal year 2024. Furthermore, the lawsuit alleges that the company&#8217;s goodwill was overstated. These alleged inaccuracies, the complaint contends, resulted in materially misleading statements about Maravai&#8217;s &hellip; Continue reading &quot;Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action Lawsuit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-17T17:33:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2642979\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action Lawsuit\",\"datePublished\":\"2025-03-17T17:33:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\\\/\"},\"wordCount\":496,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2642979\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\\\/\",\"name\":\"Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action Lawsuit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2642979\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"datePublished\":\"2025-03-17T17:33:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2642979\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2642979\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action Lawsuit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action Lawsuit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/","og_locale":"en_US","og_type":"article","og_title":"Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action Lawsuit - Market Newsdesk","og_description":"PR Newswire NEW YORK , March 17, 2025 \/PRNewswire\/ &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP announces the filing of a securities class action lawsuit against Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). This lawsuit, filed on behalf of those who purchased Maravai securities between August 7, 2024, and February 24, 2025, alleges that the company made materially misleading statements and failed to disclose crucial information to investors. The complaint alleges several key issues. Specifically, it claims Maravai lacked sufficient internal controls over financial reporting concerning revenue recognition, leading to inaccurate revenue reporting for fiscal year 2024. Furthermore, the lawsuit alleges that the company&#8217;s goodwill was overstated. These alleged inaccuracies, the complaint contends, resulted in materially misleading statements about Maravai&#8217;s &hellip; Continue reading \"Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action Lawsuit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-17T17:33:14+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2642979\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action Lawsuit","datePublished":"2025-03-17T17:33:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/"},"wordCount":496,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2642979\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/","name":"Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action Lawsuit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2642979\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","datePublished":"2025-03-17T17:33:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2642979\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2642979\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maravai-lifesciences-holdings-inc-mrvi-faces-securities-class-action-lawsuit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action Lawsuit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/826446","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=826446"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/826446\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=826446"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=826446"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=826446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}